Also known as: Serelaxin, RLX-030

Relaxin is a compound in the cardiovascular research space. It is classified as Tier 2 — Clinical Trials in the Peptidings evidence framework, with a verdict of Eyes Open.

📖 Read the full Relaxin research overview →

Evidence Tier: Tier 2 — Clinical Trials · Peptidings Verdict: Eyes Open